Article Figures & Data
Tables
- Table 1
- The selected cytochrome P450 2D6 single nucleotide polymorphisms for this study.
SNP ID/name Position reference SNP region Genetic variation Functional consequence Phenotype prediction* Global MAF† rs1080985 (CYP2D6*2) NC_000022.11:g.42132375G>C Promotor 2KB upstream variant No function - Samples = 14,996
G = 0.87 (Ref)
C = 0.13 (Alt)rs28624811 (CYP2D6*36) NC_000022.11:g.42131531G>A Promotor 2KB upstream variant No function - Samples = 55,678
G = 0.66 (Ref)
A = 0.34 (Alt)rs1065852 (CYP2D6*4) NC_000022.11:g.42130692G>A Exon 1 Missense variant; splice defect Decreased function PM Samples = 48,628
G = 0.79 (Ref)
A = 0.21 (Alt)rs28371725 (CYP2D6*41) NC_000022.11:g.42127803C>T Intron 6 Intron variant; splice defect Decreased function IM-PM Samples = 43,504
C = 0.91 (Ref)
T = 0.09 (Alt)rs1135840 (CYP2D6*10) NC_000022.11:g.42126611C>G Exon 9 Missense variant Decreased function IM-PM Samples = 24,724
C = 0.43 (Ref)
G = 0.57 (Alt)↵* Phenotype prediction is based on Clinical Pharmacogenetics Implementation Consortium recommendations. †Global minor allele frequency is based on Allele Frequency Aggregator project database. Alt: alternative allele, CYP2D6: cytochrome P450 2D6, ID: identification, IM: intermediate metabolizers, SNP: single nucleotide polymorphism, MAF: minor allele frequency, PM: poor metabolizers, Ref: reference allele
- Table 2
- Genotype and allele frequencies of the selected cytochrome P450 2D6 single nucleotide polymorphisms in the study sample (N=107).
SNPs Genotypes (N=107) Alleles (N=214) P-values (for HWE) rs1080985 G/G G/C C/C G C 0.90 56 (52.3) 43 (40.2) 8 (7.5) 155 (72.4) 59 (27.6) rs28624811 G/G G/A A/A G A 0.77 30 (28.0) 52 (48.6) 25 (23.4) 112 (52.3) 102 (47.7) rs1065852 G/G G/A A/A G A <0.001 80 (74.8) 14 (13.1) 13 (12.2) 174 (81.3) 40 (18.7) rs28371725 C/C C/T T/T C T 0.86 76 (71.0) 29 (27.1) 2 (1.9) 181 (84.6) 33 (15.4) rs1135840 G/G G/C C/C G C 0.36 40 (37.4) 55 (51.4) 12 (11.2) 135 (63.1) 79 (36.9) Values are presented as numbers and precentages (%). P-values above 0.05 represents consistency of CYP2D6 genotypes with HWE principle. HWE: Hardy-Weinberg equilibrium, SNPs: single nucleotide polymorphisms - Table 3
- Characteristics of the study sample stratified by the cytochrome P450 2D6 single nucleotide polymorphism genotypes.
Variables CYP2D6 genotypes rs1080985 rs28624811 rs1065852 rs28371725 rs1135840 0 (n=56) 1 (n=51) 0 (n=30) 1 (n=77) 0 (n=80) 1 (n=27) 0 (n=76) 1 (n=31) 0 (n=40) 1 (n=67) Age, mean±SD 38.5±10.4 36.6±12.2 37.1±10.1 37.8±11.8 38.7±11.4 34.3±10.8 37.6±11.1 37.5±12.1 35.4±11.1 38.9±11.3 P-values 0.37 0.77 0.08 0.97 0.12 Gender (n=91) 48 43 26 65 67 24 67 24 34 57 P-values 0.84 0.77 0.52 0.16 0.99 Cutaneous (n=83) 45 38 25 58 61 22 59 24 31 52 P-values 0.47 0.37 0.57 0.98 0.99 Arthritis (n=86) 44 42 23 63 62 24 61 25 33 53 P-values 0.62 0.55 0.20 0.96 0.67 Serositis (n=20) 6 14 4 16 18 2 15 5 8 12 P-values 0.03 0.37 0.08 0.66 0.79 Renal (n=50) 29 21 19 31 35 15 38 12 20 30 P-values 0.27 0.03 0.29 0.29 0.60 Neurological (n=19) 7 12 2 17 16 3 13 6 10 9 P-values 0.14 0.06 0.30 0.78 0.13 Hematological (n=47) 23 24 14 33 32 15 34 13 22 25 P-values 0.53 0.72 0.16 0.79 0.07 Immunological (n=92) 45 47 24 68 68 24 66 26 36 56 P-values 0.08 0.27 0.61 0.69 0.35 Values are presented as numbers or proportion in a subgroup. P-values (Bonferroni-adjusted) below 0.05 represents a statistically significant relationship (contingency) between CYP2D6 genotypes and participant characteristics. CYP2D6: cytochrome P450 2D6, SD: standard deviation, SNP: single nucleotide polymorphism, CYP2D6 SNP genotype 0: reference variant (homozygous dominant), CYP2D6 SNP genotype 1: alternative variants (heterozygous and homozygous recessive) - Table 4
- Univariate logistical regression of systemic lupus erythematosus feature (dependent variable) on recessive cytochrome P450 2D6 genotype (explanatory variable).
Variables Unadjusted model Adjusted model* OR 95% CI P-values OR 95% CI P-values Cutaneous rs1080985 (1) 0.71 0.29-1.78 0.47 0.65 0.25-1.68 0.38 rs28624811 (1) 0.61 0.21-1.82 0.38 0.63 0.21-1.95 0.43 rs1065852 (1) 1.37 0.46-4.11 0.57 1.08 0.34-3.40 0.90 rs28371725 (1) 0.99 0.36-2.69 0.98 1.08 0.38-3.08 0.89 rs1135840 (1) 1.01 0.39-2.57 0.99 1.20 0.45-3.20 0.72 Arthritis rs1080985 (1) 1.27 0.49-3.33 0.62 1.29 0.47-3.51 0.62 rs28624811 (1) 1.37 0.49-3.82 0.55 1.48 0.51-4.31 0.47 rs1065852 (1) 2.32 0.63-8.61 0.21 2.09 0.54-8.11 0.28 rs28371725 (1) 1.02 0.36-2.94 0.96 1.27 0.42-3.91 0.67 rs1135840 (1) 0.80 0.29-2.20 0.67 0.83 0.29-2.36 0.72 Serositis rs1080985 (1) 3.15 1.11-8.98 0.03 3.01 1.05-8.66 0.04 rs28624811 (1) 1.70 0.52-5.59 0.38 1.71 0.52-5.66 0.38 rs1065852 (1) 0.28 0.06-1.28 0.10 0.24 0.05-1.13 0.07 rs28371725 (1) 0.78 0.26-2.38 0.66 0.73 0.23-2.27 0.58 rs1135840 (1) 0.87 0.32-2.36 0.79 0.95 0.35-2.63 0.93 Renal rs1080985 (1) 0.65 0.3-1.40 0.27 0.59 0.27-1.30 0.19 rs28624811 (1) 0.39 0.16-0.93 0.03 0.39 0.16-0.94 0.04 rs1065852 (1) 1.61 0.67-3.87 0.29 1.39 0.56-3.43 0.48 rs28371725 (1) 0.63 0.27-1.48 0.29 0.62 0.26-1.50 0.29 rs1135840 (1) 0.81 0.37-1.78 0.60 0.92 0.41-2.06 0.83 Neurological rs1080985 (1) 2.15 0.77-5.99 0.14 2.11 0.75–5.91 0.16 rs28624811 (1)) 3.97 0.86-18.36 0.08 4.13 0.89–19.24 0.07 rs1065852 (1 0.50 0.13-1.87 0.30 0.43 0.11–1.66 0.22 rs28371725 (1) 1.16 0.40-3.40 0.78 1.22 0.41–3.63 0.72 rs1135840 (1) 0.47 0.17-1.27 0.13 0.49 0.18–1.35 0.17 Hematological rs1080985 (1) 1.28 0.59-2.74 0.53 1.18 0.54-2.60 0.67 rs28624811 (1) 0.86 0.37-2.00 0.72 0.87 0.37-2.07 0.75 rs1065852 (1) 1.87 0.78-4.53 0.16 1.63 0.66-4.03 0.29 rs28371725 (1) 0.89 0.38-2.08 0.79 0.88 0.37-2.12 0.78 rs1135840 (1) 0.49 0.22-1.08 0.08 0.54 0.24-1.22 0.14 Immunological rs1080985 (1) 2.87 0.85-9.68 0.09 3.00 0.87-10.31 0.08 rs28624811 (1) 1.89 0.61-5.86 0.27 1.96 0.62-6.19 0.25 rs1065852 (1) 1.41 0.37-5.44 0.62 1.34 0.34-5.30 0.68 rs28371725 (1) 0.79 0.25-2.53 0.69 0.88 0.27-2.89 0.83 rs1135840 (1) 0.57 0.17-1.91 0.36 0.56 0.16-1.92 0.36 ↵* Model adjusted for age and gender. P-values below 0.05 represents a statistically significant association between clinical features of systemic lupus erythematosus and variant CYP2D6 genotypes. Bootstrap test based on 1000 samples (bias corrected and accelerated method) was carried out to verify statistically significant findings. CI: confidence interval, OR: odds ratio, SNP: single nucleotide polymorphism, CYP2D6 SNP genotype (1): heterozygous or homozygous recessive versus homozygous dominant genotypes